NeuroPace Inc Contracts & Agreements
35 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (8)
- Human Resources (4)
- Real Estate (1)
- Uncategorized (9)
- Description of securities (Filed With SEC on March 5, 2024)
- Transition and Separation Agreement, dated February 7, 2024, by and between the Company and Irina Ridley (Filed With SEC on March 5, 2024)
- Supply Agreement, dated (Filed With SEC on March 5, 2024)
- First Amendment to (Filed With SEC on March 5, 2024)
- Second Amendment to Supply Agreement, dated January 1, 2021, by and between the Company and Greatbatch Ltd (Filed With SEC on March 5, 2024)
- NeuroPace, Inc. 2023 Inducement Plan, Form of Stock Option Grant Notice, and Form of Stock Option Agreement (Filed With SEC on July 19, 2023)
- Consulting Agreement dated June 28, 2023, by and between NeuroPace and Michael Favet (Filed With SEC on June 28, 2023)
- Offer Letter dated June 27, 2023, by and between the NeuroPace and Joel Becker (Filed With SEC on June 28, 2023)
- Second Amendment to Term Loan (Filed With SEC on May 4, 2023)
- Amendment 1 to Supply Agreement, dated November 16, 2022, by and between the Company and Micro Systems Technologies, Inc (Filed With SEC on May 4, 2023)
- Description of securities (Filed With SEC on March 2, 2023)
- Second Amendment to Office Lease, dated August 22, 2022, by and between the Company and BXP Research Park LP (f/k/a BP MV Research Park LLC) (Filed With SEC on November 8, 2022)
- Exclusive Distribution Agreement, dated August 9, 2022, by and between the Company and DIXI Medical USA Corp (Filed With SEC on November 8, 2022)
- First Amendment to Term Loan Agreement, dated September 24, 2020, by among the Company, the Subsidiary Guarantors from time to time party thereto, the Lenders from time to time... (Filed With SEC on May 12, 2022)
- Description of securities (Filed With SEC on March 10, 2022)
- Form of Underwriting Agreement (Filed With SEC on April 14, 2021)
- Form of common stock certificate of the Registrant (Filed With SEC on April 14, 2021)
- 2021 Equity Incentive Plan (Filed With SEC on April 14, 2021)
- Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under 2021 Equity Incentive Plan (Filed With SEC on April 14, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on April 14, 2021)
- Form of Indemnification Agreement, by and between the Registrant and each of its directors and executive officers (Filed With SEC on April 14, 2021)
- Supply Agreement, dated November 16, 2015, by and between the Company and Micro Systems Technologies Management AG (Filed With SEC on April 14, 2021)
- Amendment One to the Supply Agreement, dated December 21, 2020, by and between the Company and Micro Systems Engineering, Inc (Filed With SEC on April 14, 2021)
- Supply Agreement, dated January 1, 2021, by and between the Company and Greatbatch Ltd (Filed With SEC on April 14, 2021)
- Amended and Restated Investors Rights Agreement, dated August 19, 2020, by and among the Registrant and the investors listed on Exhibit A thereto (Filed With SEC on March 24, 2021)
- 2009 Stock Plan (Filed With SEC on March 24, 2021)
- Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2009 Stock Plan (Filed With SEC on March 24, 2021)
- 2020 Stock Plan (Filed With SEC on March 24, 2021)
- Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the 2020 Stock Plan (Filed With SEC on March 24, 2021)
- Amended and Restated (Filed With SEC on March 24, 2021)
- Amended and Restated (Filed With SEC on March 24, 2021)
- Amended and Restated Offer Letter, dated March 24, 2021, by and between the Company and Martha Morell, M.D (Filed With SEC on March 24, 2021)
- Amended and Restated Offer Letter, dated (Filed With SEC on March 24, 2021)
- Form of Warrant to purchase shares of common stock (Filed With SEC on March 24, 2021)
- Form of Warrant to purchase shares of Series B convertible preferred stock (Filed With SEC on March 24, 2021)